Capacity scale-ups to drive Epigral’s ₹5,000 crore target by FY31: CMD

The company expects to reach ₹2,900 crore in revenue this fiscal year following revenue of ₹2,500-2,530 crore in 2026
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.